Assertio Therapeutics Inc.
13F holders, Q2 2024 (June 30)1holders
$0.00avg. 13F price*
At the end of Q2 2024, 1 institutions reported holding Assertio Therapeutics Inc. in their 13F filings. The largest holder was AlphaMark Advisors, LLC ($0).
- Company
- Assertio Therapeutics Inc.
- CUSIP
- 04545L107
- Latest filing quarter
- Q2 2024
Total Exit/New Position Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| AlphaMark Advisors, LLC | 0.00% | New | 37 | $0 |
"% of holder's portfolio" is ASSERTIO THERAPEUTICS INC's weight in each manager's 13F, not the share of Assertio Therapeutics Inc. the manager owns.